Document is current
Any future updates will be listed below
-
Authors
Göller, Selma
Nickel, Kathrin
Horster, Isabelle
Endres, Dominique
Zeeck, Almut
Domschke, Katharina
Lahmann, Claas
Tebartz van Elst, Ludger
Maier, Simon
Joos, Andreas A. B.
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (JO 744/2-1)
Universitätsklinikum Freiburg
- License Information
-
More Information
Article History
Received: 19 March 2022
Accepted: 23 May 2022
First Online: 31 May 2022
Declarations
:
: The study was approved by the Ethics Committee of the University of Freiburg (EK 520/13). Study participants gave written informed consent to participate in the study.
: All authors gave consent to the publication of the manuscript.
: SG: no conflict of interest, KN: no conflict of interest, IH: no conflict of interest, DE: no conflict of interest, AZ: no conflict of interest, KD: Member of the ‘Steering Committee Neurosciences’, Janssen Pharmaceuticals, Inc., CL: no conflict of interest, LTvE: Advisory boards, lectures, or travel grants within the last three years: Roche, Eli Lilly, Janssen-Cilag, Novartis, Shire, UCB, GSK, Servier, Janssen and Cyberonics, SM: no conflict of interest, AJ: no conflict of interest.
